Differding Consulting s.p.r.l. was established in 2010 to offer strategic advice on drug discovery activities to pharmaceutical companies, biotech companies and research institutes.
We focus on two areas:
Differding Consulting s.p.r.l. is based in Louvain-la-Neuve (Belgium), South of Brussels, and is building on an expanding global network with contract research organizations, in particular in Asia, and a special focus on India.
20.08.15 | DRUG DISCOVERY AND DEVELOPMENT ALLIANCES IN INDIA – UPDATE ON RECENT OUT-LICENSING DEALS
Global pharmaceutical companies including Hoffmann-La Roche, Boehringer Ingelheim, or Pierre Fabre have recently signed major licensing deals with Indian biotech companies to acquire the rights to preclinical development candidates. Cancer is the leading therapeutic indication covered by these deals, with approaches ranging from immuno-oncology to epigenetics, and covering both small molecules and peptides.
26.02.14 | AUNP-12 - A NOVEL PEPTIDE THERAPEUTIC TARGETING PD-1 IMMUNE CHECKPOINT PATHWAY FOR CANCER IMMUNOTHERAPY – STRUCTURE ACTIVITY RELATIONSHIPS & PEPTIDE / PEPTIDOMIMETIC ANALOGS